Deferring treatment with pirfenidone results in loss of lung function that is not recovered by later treatment initiation

T. Maher (1) , S. Jouneau (2) , L. Morrison (3) , D. Lederer (4) , M. Molina-Molina (5) , K-U Kirchgaessler , F. Gilberg , J. Axmann , U. Petzinger , E. Bendstrup

1 Imperial College London
2 Irset - Institut de recherche en santé, environnement et travail
3 Duke University [Durham]
4 UBC - University of British Columbia
5 CIBERES - Centro de Investigación Biomédica en Red Enfermedades Respiratorias

Domains: Life Sciences [q-bio]; Santé publique et épidémiologie

T. Maher, S. Jouneau, L. Morrison, D. Lederer, M. Molina-Molina, et al.. Deferring treatment with pirfenidone results in loss of lung function that is not recovered by later treatment initiation. Thorax, 2017, 72, pp.A251-A252. ⟨10.1136/thoraxjnl-2017-210983.450⟩. ⟨hal-01863043⟩